Gestational diabetes mellitus;Gestationsdiabetes (GDM)

Wiener Klinische Wochenschrift

Volumn 128, Issue , 2016, Pages 103-112

  Kautzky Willer, Alexandra ^a   Harreiter, Jürgen ^a   Bancher Todesca, Dagmar ^b   Berger, Angelika ^c   Repa, Andreas ^c   Lechleitner, Monika ^d   Weitgasser, Raimund ^d,e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^d Abteilung fur Innere Medizin   (Austria)

^e Salzburger Landeskliniken   (Austria)

Author keywords

Diabetic fetopathy; Gestational diabetes; Overweight obesity; Pregnancy; Risk of diabetes

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN;

ANALYSIS; AUSTRIA; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES, GESTATIONAL; DIAGNOSTIC IMAGING; DIET THERAPY; DOSE RESPONSE; DRUG ADMINISTRATION; EVIDENCE BASED MEDICINE; FEMALE; FETUS MONITORING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; KINESIOTHERAPY; PRACTICE GUIDELINE; PREGNANCY; STANDARDS; TREATMENT OUTCOME;

AUSTRIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES, GESTATIONAL; DIET THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; EXERCISE THERAPY; FEMALE; FETAL MONITORING; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; TREATMENT OUTCOME;

EID: 84962659270     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-015-0941-1     Document Type: Article

References (33)

1. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9. doi:10.1016/S0140-6736(09)60731-5.
2. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet. 2009;373(9677):1789–97. doi:10.1016/S0140-6736(09)60515-8.
3. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86. doi:10.1056/NEJMoa042973.
4. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev. 2009(3):CD003395. doi:10.1002/14651858.CD003395.pub2.
5. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, et al. The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab. 2008;93(5):1689–95. doi:10.1210/jc.2007-2301.
6. Bozkurt L, Göbl CS, Pfligl L, et al. Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. J Clin Endocrinol Metab. 2015;100(3):1113–20. doi:10.1210/jc.2014-4055.
7. Kleinwechter H, Schäfer-Graf U, Bührer C, et al. Gestationsdiabetes mellitus (GDM) – Diagnostik, Therapie und Nachsorge. Evidenzbasierte Leitlinie zu Diagnostik, Therapie und Nachsorge der Deutschen Diabetes-Gesellschaft (DDG) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). DDG (Kellerer M, Matthaei S) und DGGG (Kreienberg R). 2011 [cited 2015]: Available from: http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/Gestationsdiabetes_EbLL_Endfassung_2011_08_11_.pdf.
8. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. doi:10.2337/dc09-1848.
9. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO reference number: WHO/NMH/MND/13.2. 2013. http://www.who.int/diabetes/publications/Hyperglycaemia_In_Pregnancy/en/. Zugegriffen: 18. Mai 2015.
10. Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227–49. doi:10.1210/jc.2013-2465.
11. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. doi:10.1056/NEJMoa0707943.
12. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453–9. doi:10.2337/db08-1112.
13. Göbl CS, Bozkurt L, Rivic P, et al. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia. 2012;55(12):3173–81. doi:10.1007/s00125-012-2726-7.
14. Institute of Medicine. Weight Gain During Pregnancy: Reexamining the Guidelines. 2009. http://iom.edu/~/media/Files/Report%20Files/2009/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines/Report%20Brief%20-%20Weight%20Gain%20During%20Pregnancy.pdf. Zugegriffen: 24. Juni 2015
15. Simmons D, Jelsma JG, Galjaard S, et al. Results from a European multicenter randomized trial of physical activity and/or healthy eating to reduce the risk of gestational diabetes mellitus: the DALI lifestyle pilot. Diabetes Care. 2015;38(9):1650–6. doi:10.2337/dc15-0360.
16. Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749–56. doi:10.1007/s00404-015-3692-3.
17. Nicholson W, Bolen S, Witkop CT, et al. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009;113(1):193–205. doi:10.1097/AOG.0b013e318190a459.
18. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15. doi:10.1056/NEJMoa0707193.
19. Ijas H, Vaarasmaki M, Morin-Papunen L, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011;118(7):880–5. doi:10.1111/j.1471-0528.2010.02763.x.
20. Balsells M, Garcia-Patterson A, Sola I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102. doi:10.1136/bmj.h102.
21. Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279–84. doi:10.2337/dc11-0660.
22. Battin MR, Obolonkin V, Rush E, et al. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial. BMC Pediatr. 2015;15:54. doi:10.1186/s12887-015-0372-1.
23. Camelo Castillo W, Boggess K, Sturmer T, et al. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr. 2015;169(5):452–8. doi:10.1001/jamapediatrics.2015.74.
24. Betreuung von Neugeborenen diabetischer Mütter. Leitlinie der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin, der Deutschen Gesellschaft für Perinatale Medizin, der Deutschen Diabetes-Gesellschaft, der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin und der Dt. Ges. f. Gynäkologie und Geburtshilfe. Frauenarzt. 2003;44(4):439–41.
25. Chertok IR, Raz I, Shoham I, et al. Effects of early breastfeeding on neonatal glucose levels of term infants born to women with gestational diabetes. J Hum Nutr Diet. 2009;22(2):166–9. doi:10.1111/j.1365-277X.2008.00921.x.
26. Hillier TA, Pedula KL, Schmidt MM, et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care. 2007;30(9):2287–92. doi:10.2337/dc06-2361.
27. Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774–9. doi:10.1210/jc.2008–0772.
28. Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646–53. doi:10.1210/jc.20143761.
29. Göbl CS, Bozkurt L, Prikoszovich T, et al. Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol. 2011;118(1):71–8. doi:10.1097/AOG.0b013e318220e18f.
30. Göbl CS, Bozkurt L, Yarragudi R, et al. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? Acta Diabetol. 2014;51(5):715–22. doi:10.1007/s00592-014-0574-2.
31. Ziegler AG, Wallner M, Kaiser I, et al. Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes. 2012;61(12):3167–71. doi:10.2337/db12-0393.
32. Xiang AH, Kawakubo M, Kjos SL, et al. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care. 2006;29(3):613–7. doi:10.2337/diacare.29.03.06.dc05-1940.
33. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31(8):1668–9. doi:10.2337/dc08-0706.